NXT USA partners with Infinity Pharma to launch Digexin in Brazil under the brand name of Motility

Photo © AdobeStock.com/BillionPhotos.com

NXT USA (Edison, NJ) has announced the launch of its Digexin ingredient in Brazil under the brand name Motility, in partnership with Infinity Pharma Brazil. The launch took place at the largest event in the world for the compound pharmacy market, Consulfarma Congress. Digexin is a proprietary blend of Withania somnifera root, known as ashwagandha, and Abelmoschus esculentus fruit, commonly known as okra, designed to support the gut-brain axis. Recently published research found that Digexin supported bowel regularity in participants with functional constipation, improving the quality of life of people taking the blend.

"We are thrilled to introduce Digexin as Motility in Brazil, especially at such a prestigious event," said Eric Anderson, managing director of NXT USA, in a press release. "Brazil can be a very challenging market for new dietary supplements, but with Infinity Pharma we have found a partner who can open the doors for this unique digestive health supplement to the Brazilian market through their relationships with doctors, pharmacists, and nutritionists.”

“We are very excited to bring this innovative plant-based digestive health product to the Brazilian market under the brand name Motility,” added Daniela Pavanelli, product manager with Infinity Pharma. “By promoting calm, complete digestion Motility not only addresses gastrointestinal symptoms but also contributes to mental and emotional well-being, offering unique advantages to consumers looking for digestive health support.”